These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20508906)

  • 1. Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase.
    Moore C; Tymvios C; Emerson M
    Thromb Haemost; 2010 Aug; 104(2):342-9. PubMed ID: 20508906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
    Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct role and location of the endothelial isoform of nitric oxide synthase in regulating platelet aggregation in males and females in vivo.
    Moore C; Sanz-Rosa D; Emerson M
    Eur J Pharmacol; 2011 Jan; 651(1-3):152-8. PubMed ID: 21118684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo.
    Apostoli GL; Solomon A; Smallwood MJ; Winyard PG; Emerson M
    J Thromb Haemost; 2014 Nov; 12(11):1880-9. PubMed ID: 25163536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase.
    Tymvios C; Moore C; Jones S; Solomon A; Sanz-Rosa D; Emerson M
    Br J Pharmacol; 2009 Dec; 158(7):1735-42. PubMed ID: 19912226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
    Kumar A; Sushama A; Manral S; Sinha R; Joshi R; Singh U; Rohil V; Prasad AK; Parmar VS; Raj HG
    Nitric Oxide; 2012 Jan; 26(1):9-19. PubMed ID: 22100620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eNOS-dependent vascular interaction between nitric oxide and calcitonin gene-related peptide in mice: gender selectivity and effects on blood aggregation.
    Lee WI; Xu Y; Fung SM; Fung HL
    Regul Pept; 2003 Jan; 110(2):115-22. PubMed ID: 12527144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of nitric oxide production contributes to the antiplatelet and antithrombotic effect of new peptide pENW (pGlu-Asn-Trp).
    Liu Y; Luo W; Yang H; Fang W; Xi T; Li Y; Xiong J
    Thromb Res; 2015 Aug; 136(2):319-27. PubMed ID: 26028472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation.
    Radziwon-Balicka A; Lesyk G; Back V; Fong T; Loredo-Calderon EL; Dong B; El-Sikhry H; El-Sherbeni AA; El-Kadi A; Ogg S; Siraki A; Seubert JM; Santos-Martinez MJ; Radomski MW; Velazquez-Martinez CA; Winship IR; Jurasz P
    Cardiovasc Res; 2017 Dec; 113(14):1719-1731. PubMed ID: 29016749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
    Emerson M; Momi S; Paul W; Alberti PF; Page C; Gresele P
    Thromb Haemost; 1999 Jun; 81(6):961-6. PubMed ID: 10404776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation.
    Ozüyaman B; Gödecke A; Küsters S; Kirchhoff E; Scharf RE; Schrader J
    Thromb Haemost; 2005 Jun; 93(6):1161-7. PubMed ID: 15968403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
    Yemisci M; Ay H; Kocaefe C; Qui J; Topalkara K; Ozgüç M; Kirazli S; Ozcebe O; Moskowitz MA; Dalkara T
    Cerebrovasc Dis; 2008; 26(2):190-8. PubMed ID: 18628618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
    Gericke A; Goloborodko E; Sniatecki JJ; Steege A; Wojnowski L; Pfeiffer N
    Exp Eye Res; 2013 Apr; 109():60-6. PubMed ID: 23434456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide as a modulator in platelet- and endothelium-dependent antithrombotic effect of eplerenone in diabetic rats.
    Gromotowicz-Poplawska A; Kloza M; Aleksiejczuk M; Marcinczyk N; Szemraj J; Kozlowska H; Chabielska E
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice.
    Laspas P; Goloborodko E; Sniatecki JJ; Kordasz ML; Manicam C; Wojnowski L; Li H; Patzak A; Pfeiffer N; Gericke A
    Exp Eye Res; 2014 Oct; 127():1-8. PubMed ID: 25017185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase.
    van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs.
    Gresele P; Momi S; Guglielmini G
    Biochem Pharmacol; 2019 Aug; 166():300-312. PubMed ID: 31173724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.
    Symons JD; McMillin SL; Riehle C; Tanner J; Palionyte M; Hillas E; Jones D; Cooksey RC; Birnbaum MJ; McClain DA; Zhang QJ; Gale D; Wilson LJ; Abel ED
    Circ Res; 2009 May; 104(9):1085-94. PubMed ID: 19342603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway.
    Muñoz YC; Gomez GI; Moreno M; Solis CL; Valladares LE; Velarde V
    Horm Metab Res; 2012 Jul; 44(8):625-31. PubMed ID: 22517552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial NO Production Is Mandatory for Epigallocatechin-3-Gallate-induced Vasodilation: Results From eNOS Knockout (eNOS-/-) Mice.
    Lorenz M; Klinkner L; Baumann G; Stangl K; Stangl V
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):607-10. PubMed ID: 25714597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.